Ki-67 proliferation index in glioma tissue was significantly higher in the multiple primary group (p = 0.045), and these patients were also significantly more likely to have IDH-wildtype gliomas (p = 0.024). This evidence concerns the gene IDH2 and central nervous system cancer.